| Comparison of health-related quality of life 5 years after SPIRIT: Surgical Prostatectomy Versus Interstitial Radiation Intervention Trial JM Crook, A Gomez-Iturriaga, K Wallace, C Ma, S Fung, S Alibhai, ... Journal of Clinical Oncology 29 (4), 362-368, 2011 | 217 | 2011 |
| Metastasis-directed therapy in treating nodal oligorecurrent prostate cancer: a multi-institutional analysis comparing the outcome and toxicity of stereotactic body … E De Bleser, BA Jereczek-Fossa, D Pasquier, T Zilli, N Van As, S Siva, ... European urology 76 (6), 732-739, 2019 | 126 | 2019 |
| Dose escalation to dominant intraprostatic lesions with MRI-transrectal ultrasound fusion High-Dose-Rate prostate brachytherapy. Prospective phase II trial A Gomez-Iturriaga, F Casquero, A Urresola, A Ezquerro, JI Lopez, ... Radiotherapy and Oncology 119 (1), 91-96, 2016 | 89 | 2016 |
| PEACE V–Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): A study protocol for a randomized controlled phase II trial A De Bruycker, A Spiessens, P Dirix, N Koutsouvelis, I Semac, ... BMC cancer 20, 1-12, 2020 | 71 | 2020 |
| A prospective analysis of factors that influence weight loss in patients undergoing radiotherapy J Cacicedo, F Casquero, L Martinez-Indart, O Del Hoyo, AG de Iturriaga, ... Chinese journal of cancer 33 (4), 204, 2014 | 55 | 2014 |
| The role of re-irradiation of secondary and recurrent head and neck carcinomas. Is it a potentially curative treatment? A practical approach J Cacicedo, A Navarro, F Alongi, AG de Iturriaga, O Del Hoyo, E Boveda, ... Cancer treatment reviews 40 (1), 178-189, 2014 | 55 | 2014 |
| Role of fluorine-18 fluorodeoxyglucose PET/CT in head and neck oncology: the point of view of the radiation oncologist J Cacicedo, A Navarro, O Del Hoyo, A Gomez-Iturriaga, F Alongi, ... The British journal of radiology 89 (1067), 20160217, 2016 | 54 | 2016 |
| Incidence of pain flare following palliative radiotherapy for symptomatic bone metastases: multicenter prospective observational study A Gomez-Iturriaga, J Cacicedo, A Navarro, V Morillo, P Willisch, ... BMC Palliative Care 14, 1-7, 2015 | 54 | 2015 |
| Median 5 Year follow-up of 125Iodine brachytherapy as monotherapy in men aged≤ 55 years with favorable prostate cancer AGI Piña, J Crook, J Borg, G Lockwood, N Fleshner Urology 75 (6), 1412-1416, 2010 | 50 | 2010 |
| Recommendations for radiation therapy in oligometastatic prostate cancer: An ESTRO-ACROP Delphi consensus T Zilli, V Achard, A Dal Pra, N Schmidt-Hegemann, BA Jereczek-Fossa, ... Radiotherapy and Oncology 176, 199-207, 2022 | 49 | 2022 |
| Oligometastatic prostate cancer: the game is afoot A Lancia, T Zilli, V Achard, P Dirix, W Everaerts, A Gomez-Iturriaga, ... Cancer treatment reviews 73, 84-90, 2019 | 44 | 2019 |
| Clinical applications of molecular biomarkers in prostate cancer F Couñago, F Lopez-Campos, AA Díaz-Gavela, E Almagro, ... Cancers 12 (6), 1550, 2020 | 37 | 2020 |
| Biochemical disease-free rate and toxicity for men treated with iodine-125 prostate brachytherapy with D90≥ 180 Gy AGI Piña, J Crook, J Borg, C Ma International Journal of Radiation Oncology* Biology* Physics 78 (2), 422-427, 2010 | 35 | 2010 |
| Phase I–II trial of perioperative high-dose-rate brachytherapy in oral cavity and oropharyngeal cancer R Martínez-Monge, A Gómez-Iturriaga, M Cambeiro, C Garrán, ... Brachytherapy 8 (1), 26-33, 2009 | 33 | 2009 |
| Is argon plasma coagulation an effective and safe treatment option for patients with chronic radiation proctitis after high doses of radiotherapy E Hortelano, A Gómez-Iturriaga, R Ortiz-de-Zárate, M Zaballa, Á Barturen, ... Rev Esp Enferm Dig 106 (3), 165-170, 2014 | 32 | 2014 |
| Dosimetric analysis of the patterns of local failure observed in patients with locally advanced non-small cell lung cancer treated with neoadjuvant chemotherapy and concurrent … M Moreno-Jiménez, J Aristu, JM López-Picazo, LI Ramos, A Gúrpide, ... Radiotherapy and Oncology 88 (3), 342-350, 2008 | 32 | 2008 |
| The efficacy of hyperbaric oxygen therapy in the treatment of medically refractory soft tissue necrosis after penile brachytherapy A Gomez-Iturriaga, J Crook, W Evans, EP Saibishkumar, J Jezioranski Brachytherapy 10 (6), 491-497, 2011 | 28 | 2011 |
| Radium-223 within the evolving treatment options for metastatic castration-resistant prostate cancer: recommendations from a European Expert Working Group JM O'Sullivan, J Carles, R Cathomas, A Gomez-Iturriaga, D Heinrich, ... European urology oncology 3 (4), 455-463, 2020 | 26 | 2020 |
| Prognostic value of maximum standardized uptake value measured by pretreatment 18F-FDG PET/CT in locally advanced head and neck squamous cell carcinoma J Cacicedo, I Fernandez, O Del Hoyo, A Navarro, A Gomez-Iturriaga, ... Clinical and Translational Oncology 19, 1337-1349, 2017 | 26 | 2017 |
| Health-related-quality-of-life and toxicity after single fraction 19 Gy high-dose-rate prostate brachytherapy: Phase II trial A Gomez-Iturriaga, F Casquero, JI Pijoan, P Minguez, JM Espinosa, ... Radiotherapy and Oncology 126 (2), 278-282, 2018 | 24 | 2018 |
Mauricio Cambeiro VázquezUniversidad de Navarra在 unav.es 的电子邮件经过验证
